Glyclopyramide

Glyclopyramide
Clinical data
Routes of
administration
Oral
ATC code none
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 631-27-6 N
PubChem (CID) 71793
ChemSpider 64820 N
UNII KE474IKG1W YesY
KEGG D01799 YesY
ChEMBL CHEMBL2105083 N
Chemical and physical data
Formula C11H14ClN3O3S
Molar mass 303.76 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Glyclopyramide (INN, marketed under the tradename Deamelin-S) is a sulfonylurea drug used in the treatment of diabetes. It has been marketed in Japan since 1965.

It is classified as second generation.[1]

References

  1. Ozawa H, Murai Y, Ozawa T (2003). "[A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus]". Yakugaku Zasshi (in Japanese). 38 (1): 11–27. PMID 14570054.


This article is issued from Wikipedia - version of the 8/24/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.